Key Points Non-GAAP revenue rose to $281.0 million for Q2 2025, exceeding the $274.2 million non-GAAP analyst estimate and up 32% from the prior quarter on a non-GAAP basis. Non-GAAP EPS loss of ...

Exact Sciences has a multipronged approach to cancer testing. Its flagship product line is Cologuard, the market leader in stool-based screening for colorectal cancer, or CRC. Its second-largest ...

SM Energy Company (NYSE:SM) reported its fiscal Q2 2025 results on July 31, with adjusted EBITDAX for the quarter reaching ...

Discover key insights from CACI's Q4 2025 earnings call, highlighting robust growth, strategic focus on software-defined tech, and confident fiscal ...

So notwithstanding the buoyant share price, we think it's well worth asking whether Aclara Resources' cash burn is too risky. For the purpose of this article, we'll define cash bu ...

Dividend investors looking for top portfolio holdings have a range of factors that ought to be considered before jumping into ...

Key Points Non-GAAP earnings per share reached $0.52 for Q2 2025, beating expectations by $0.01, but revenue (GAAP) fell 4.9% year over year. US sales declined 18.3% (GAAP), leading to a $214 million ...

Q2 2025 Management View CEO Charles Victor Magro stated that Corteva delivered both top and bottom line growth in the second quarter, with more than 200 basis points of operating EBITDA margin ...

Investors are more concerned with the fact that despite doing all the above, Redwire's sales slowed dramatically, with ...

Pan American Silver (TSX: PAAS) reversed last year’s red with record free cash flow as it reports Q2 2025 revenue jumping 18% ...

Here are three technology giants that have generated exceptional long-term returns for shareholders and are well worth ...

Accelerating overseas growth of the food business is high on the agenda. Meiji’s lack of overseas exposure, specifically in the food business, has become an obvious drawback amid rapid inflation and ...